Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality

Cardiology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Chamaria, Surbhi ^a   Desai, Anand M ^a   Reddy, Pratap C ^a   Olshansky, Brian ^b   Dominic, Paari ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DRUG USE; FOLLOW UP; HEART FAILURE; HEART RATE; HUMAN; HYPERTENSION; MEDICAL HISTORY; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVIEW;

EID: 84953924421     PISSN: 20908016     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2015/314041     Document Type: Review

References (30)

1. Digitalis Investigation Group, "The effect of digoxin on mortality and morbidity in patients with heart failure, " The New England Journal of Medicine, vol. 336, no. 8, pp. 525-533, 1997.
2. W. B. Hood Jr., A. L. Dans, G. H. Guyatt, R. Jaeschke, and J. J. McMurray, "Digitalis for treatment of congestive heart failure in patients in sinus rhythm, " Cochrane Database of Systematic Reviews, no. 2, Article ID CD002901, 2004.
3. A.-J. Ouyang, Y.-N. Lv, H.-L. Zhong et al., "Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation, " The American Journal of Cardiology, vol. 115, no. 7, pp. 901-906, 2015.
4. M. Vamos, J. W. Erath, and S. H. Hohnloser, "Digoxinassociated mortality: a systematic review and meta-analysis of the literature, " European Heart Journal, vol. 36, no. 28, pp. 1831-1838, 2015.
5. D. F. Stroup, J. A. Berlin, S. C. Morton et al., "Meta-analysis of observational studies in epidemiology: a proposal for reporting, " The Journal of the AmericanMedical Association, vol. 283, no. 15, pp. 2008-2012, 2000.
6. R. P. Harris, M. Helfand, S. H. Woolf et al., "Currentmethods of the US Preventive Services Task Force: a review of the process, " American Journal of Preventive Medicine, vol. 20, no. 3, pp. 21-35, 2001.
7. M. Levine, S. Walter, H. Lee, T. Haines, A. Holbrook, and V. Moyer, "Users guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group, " The Journal of the American Medical Association, vol. 271, no. 20, pp. 1615-1619, 1994.
8. P. Hallberg, J. Lindbäck, B. Lindahl, U. Stenestrand, and H. Melhus, "Digoxin and mortality in atrial fibrillation: a prospective cohort study, " European Journal of Clinical Pharmacology, vol. 63, no. 10, pp. 959-971, 2007.
9. J. P. T. Higgins and S. G. Thompson, "Quantifying heterogeneity in ameta-analysis, " Statistics inMedicine, vol. 21, no. 11, pp. 1539-1558, 2002.
10. S. G. Thompson and J. P. T. Higgins, "How should metaregression analyses be undertaken and interpreted" Statistics in Medicine, vol. 21, no. 11, pp. 1559-1573, 2002.
11. S. G. Thompson and S. J. Sharp, "Explaining heterogeneity in meta-analysis: a comparison ofmethods, " Statistics inMedicine, vol. 18, no. 20, pp. 2693-2708, 1999.
12. M. Egger, G. D. Smith, M. Schneider, and C. Minder, "Bias in meta-analysis detected by a simple, graphical test, " BritishMedical Journal, vol. 315, no. 7109, pp. 629-634, 1997.
13. J. V. Freeman, K. Reynolds, M. Fang et al., "Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study, " Circulation: Arrhythmia and Electrophysiology, vol. 8, no. 1, pp. 49-58, 2015.
14. L. Fauchier, C. Grimard, B. Pierre et al., "Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure, " The American Journal of Cardiology, vol. 103, no. 2, pp. 248-254, 2009.
15. T.-F. Chao, C.-J. Liu, S.-J. Chen et al., "Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation A nationwide population-based cohort study, " Canadian Journal of Cardiology, vol. 30, no. 10, pp. 1190-1195, 2014.
16. M. Shah, M. Avgil Tsadok, C. A. Jackevicius, V. Essebag, H. Behlouli, and L. Pilote, "Relation of digoxin use in atrial fibrillation and the risk of all-causemortality in patients65 years of age with versus without heart failure, " The American Journal of Cardiology, vol. 114, no. 3, pp. 401-406, 2014.
17. L. A. Allen, G. C. Fonarow, D. N. Simon et al., "Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort, " Journal of the American College of Cardiology, vol. 65, pp. 2691-2698, 2015.
18. M. G. Whitbeck, R. J. Charnigo, P. Khairy et al., "Increased mortality among patients taking digoxin-analysis from the AFFIRM study, " European Heart Journal, vol. 34, no. 20, pp. 1481-1488, 2013.
19. K. Gjesdal, J. Feyzi, and S. B. Olsson, "Digitalis: a dangerous drug in atrial fibrillation An analysis of the SPORTIF III and V data, " Heart, vol. 94, no. 2, pp. 191-196, 2008.
20. M. P. Turakhia, P. Santangeli, W. C. Winkelmayer et al., "Increased mortality associated with digoxin in contemporary patients with atrial fibrillation findings from the TREAT-AF study, " Journal of the American College of Cardiology, vol. 64, pp. 660-668, 2014.
21. D. Pastori, A. Farcomeni, T. Bucci et al., "Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation, " International Journal of Cardiology, vol. 180, pp. 1-5, 2015.
22. L. Friberg, N. Hammar, and M. Rosenqvist, "Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF), " Heart, vol. 96, no. 4, pp. 275-280, 2010.
23. M. Rodŕguez-Mãnero, F. Otero-Ravĩna, J. Garća-Seara et al., "Outcomes of a contemporary sample of patients with atrial fibrillation taking Digoxin: results from the AFBAR study, " Revista Espanola de Cardiologia, vol. 67, no. 11, pp. 890-897, 2014.
24. B. A. Mulder, D. J. Van Veldhuisen, H. J. G. M. Crijns et al., "Digoxin in patients with permanent atrial fibrillation: data from the RACE II study, " Heart Rhythm, vol. 11, no. 9, pp. 1543-1550, 2014.
25. M. Gheorghiade, G. C. Fonarow, D. J. van Veldhuisen et al., "Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity- matched analysis of the AFFIRM trial, " European Heart Journal, vol. 34, no. 20, pp. 1489-1497, 2013.
26. V. V. Georgiopoulou, A. P. Kalogeropoulos, G. Giamouzis et al., Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy, " Circulation-Heart Failure, vol. 2 2 90-97 2009.
27. C. T. January, L. S. Wann, J. S. Alpert et al., "2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ AmericanHeartAssociation Task Force on PracticeGuidelines and the Heart Rhythm Society, " Journal of the American College of Cardiology, vol. 64, no. 21, pp. e1-e76, 2014.
28. S. S. Rathore, J. P. Curtis, Y. F. Wang, M. R. Bristow, and H. M. Krumholz, "Association of serum digoxin concentration and outcomes in patients with heart failure, " The Journal of the AmericanMedical Association, vol. 289, no. 7, pp. 871-878, 2003.
29. A. Mazur and M. E. Anderson, "Digoxin and cardiac arrhythmias: an update, " Cardiac Electrophysiology Review, vol. 2, no. 2, pp. 222-224, 1998.
30. J. A. Kastor and P. M. Yurchak, "Recognition of digitalis intoxication in the presence of atrial fibrillation, " Annals of Internal Medicine, vol. 67, no. 5, pp. 1045-1054, 1967.